# AIM ImmunoTech Inc.: Form 8-K, filed Feb 24, 2023

- Company: [AIM ImmunoTech Inc.](/companies/aim.md) (CIK 946644)
- Form: 8-K
- Filed: 2023-02-24
- Accepted by EDGAR: Feb 24, 2023, 15:06 ET
- Period: 2023-02-23
- Accession: 0001493152-23-005961
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/946644/000149315223005961/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/946644/000149315223005961/

## Items reported

- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/946644/000149315223005961/form8-k.htm

Filed Feb 24, 2023.
Source: SEC EDGAR, the filing index for accession 0001493152-23-005961. Last ingested by Listed: Nov 14, 2026, 11:22 ET. No prices; not investment advice.
